OverviewChartNewsTraderScreen

DZ Bank Call 1.5 MDGD 20.12.2024/  DE000DQ28EE0  /

Frankfurt Zert./DZB
28/06/2024  12:04:28 Chg.+0.010 Bid12:21:26 Ask12:21:26 Underlying Strike price Expiration date Option type
0.110EUR +10.00% 0.100
Bid Size: 10,000		 0.200
Ask Size: 10,000		 MEDIGENE AG NA O.N. 1.50 EUR 20/12/2024 Call
GlobeNewswire 27/06 Medigene Presents Efficient 6-Day TCR-T Therapy Production Process with High Stemness
GlobeNewswire 24/06 Medigene Reports Results of Annual General Meeting
GlobeNewswire 21/06 Medigene to Present at the Cell and Gene Therapy In-Depth Focus Summit 2024
GlobeNewswire 20/06 Medigene AG Announces Lead Selection for MDG2021, Expanding TCR-T KRAS Library Targeting Solid Tumor...
GlobeNewswire 11/06 Thermosome Appoints Dr. Sabine Hauck as Chief Technical Officer
GlobeNewswire 28/05 Medigene AG Expands its End-to-End Platform by Submitting Three Development Optimization Technology ...
GlobeNewswire 21/05 Medigene's Global Research & Collaboration Agreement with BioNTech to Extend Beyond Initially Announ...
GlobeNewswire 15/05 Medigene Presents Preclinical Data on Optimal Affinity TCRs Targeting the Neoantigen Mutant KRAS
GlobeNewswire 14/05 Medigene AG Extends Cash Runway into July 2025 After Successful Oversubscribed Capital Raise
GlobeNewswire 07/05 Medigene to Present at Upcoming Conferences
GlobeNewswire 06/05 The Benchmark Company Announces Upcoming Healthcare House Call VIRTUAL One-on-One Investor Conferenc...
GlobeNewswire 02/05 Medigene AG Expands Patent Portfolio with European Patent Grant for its NY-ESO-1 – targeted T Cell R...
GlobeNewswire 02/05 Medigene Presents Superior TCR-T Cell Functionality by Inclusion of a Costimulatory Switch Protein
GlobeNewswire 26/04 Medigene AG reports Financial Results and Business Update for Q1 2024
GlobeNewswire 25/04 Medigene presents streamlined 6-day, high stemness TCR-T therapy production process
GlobeNewswire 17/04 Medigene to Present at Upcoming Scientific Conferences
GlobeNewswire 08/04 Medigene Presents Favorable Safety Profile of TCR-T Cells with Costimulatory Switch Protein at AACR ...
GlobeNewswire 04/04 Medigene AG Secures European Patent for its iM-TCR Technology
GlobeNewswire 28/03 Medigene AG Reports Full-Year 2023 Financial Results and Provides Corporate Update
GlobeNewswire 19/03 Medigene AG to participate in the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference
GlobeNewswire 18/03 Medigene AG to report full year 2023 financial results on March 28, 2024
GlobeNewswire 06/03 Medigene to Present Favorable Safety Profile of TCR-T Cells upon Addition of Costimulatory Switch Pr...
GlobeNewswire 04/03 Medigene AG Expands Patent Portfolio in Japan for iM-TCR Technology to Directly Control TCR-T Safety...
GlobeNewswire 29/02 Medigene Presents at CAR-TCR Summit Europe Showcasing Unique Approach for Development of Differentia...
GlobeNewswire 19/02 Medigene to Present at Upcoming Conferences